Bang, Y., Golan, T., Dahan, L., Fu, S., Moreno, V., Park, K., Geva, R., De Braud, F., Wainberg, Z. A., Reck, M., Goff, L., Laing, N., Mi, G., Oliveira, J. M., Wasserstrom, H., & Lin, C. (2020). ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ). European journal of cancer, 137, 272–284. http://access.bl.uk/ark:/81055/vdc_100106951942.0x00002c